Specifically, it acts as an agonist (activator) for the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor
It was developed by Eli Lilly as part of a broader effort to improve on first- and second-generation incretin-based therapies
However, the specific binding kinetics differ
Mounjaro Le Mounjaro (tirzpatide) est un mdicament pour traiter le diabte de type 2 et la perte de poids : il agit la fois sur les rcepteurs du GLP-1 et du GIP (une autre hormone intestinale)
The 10 mg format is especially useful for studying: Early metabolic signaling responses Integrated hormone pathway activation Obesity and diabetes research models Future peptide-based metabolic strategies Summary In research contexts, Retatrutide 10 mg is valued for its potential benefits related to appetite control, glucose regulation, increased energy expenditure, fat oxidation, and balanced multi-pathway metabolic signaling
GLP-1 supplements aren't new just their branding is